Treatment of Female Stress Incontinence with Midodrine: Preliminary Report

Publisher Website
Google Scholar
Abstract
For 10 days 21 female patients with clinical stages I-III stress incontinence and 4 continent control female patients were treated with the .alpha.-sympathomimetic midodrine. Urethrometry revealed that .alpha.-adrenergic stimulation resulted in an increase in the urethral occlusion pressure of up to 30% and, cystometrically, to an increase in the detrusor pressure of up to 35% without impairment of bladder capacity. In the stage I group 83% and in the stage II group 63% of the patients became continent. Midodrine, the advantage of which over comparable sympathomimetics such as ephedrine, synephrine and norphenylephrine lies in the absolutely sure and sustained action in oral use, is recommended as an laternative therapy to traditional surgical procedures in the treatment of stages I and II female stress incotinence.